Trade names Marquis ATCvet code QP51AJ04 (WHO) Molar mass 457.38 g/mol | Routes of
administration Oral CAS Number 69004-04-2 | |
 | ||
AHFS/Drugs.com FDA Professional Drug Information Legal status US: ℞-only
Veterinary use only | ||
Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats, dogs, and rabbits against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
References
Ponazuril Wikipedia(Text) CC BY-SA